Boss, M.-K.; Watts, R.; Harrison, L.G.; Hopkins, S.; Chow, L.; Trageser, E.; Easton, C.; LaRue, S.M.; Regan, D.; Dewhirst, M.W.;
et al. Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy. Int. J. Mol. Sci. 2022, 23, 826.
https://doi.org/10.3390/ijms23020826
AMA Style
Boss M-K, Watts R, Harrison LG, Hopkins S, Chow L, Trageser E, Easton C, LaRue SM, Regan D, Dewhirst MW,
et al. Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy. International Journal of Molecular Sciences. 2022; 23(2):826.
https://doi.org/10.3390/ijms23020826
Chicago/Turabian Style
Boss, Mary-Keara, Remy Watts, Lauren G. Harrison, Sophie Hopkins, Lyndah Chow, Erin Trageser, Carina Easton, Susan M. LaRue, Daniel Regan, Mark W. Dewhirst,
and et al. 2022. "Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy" International Journal of Molecular Sciences 23, no. 2: 826.
https://doi.org/10.3390/ijms23020826
APA Style
Boss, M.-K., Watts, R., Harrison, L. G., Hopkins, S., Chow, L., Trageser, E., Easton, C., LaRue, S. M., Regan, D., Dewhirst, M. W., & Dow, S.
(2022). Immunologic Effects of Stereotactic Body Radiotherapy in Dogs with Spontaneous Tumors and the Impact of Intratumoral OX40/TLR Agonist Immunotherapy. International Journal of Molecular Sciences, 23(2), 826.
https://doi.org/10.3390/ijms23020826
